Health care stocks were lower Thursday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.7%.
The iShares Biotechnology ETF (IBB) fell 0.8%.
In corporate news, Bausch + Lomb (BLCO) said a go-private deal with a third-party buyer won't materialize at this time. The deal was one of the options being explored to complete a full separation from Bausch Health (BHC), it said. Bausch + Lomb shares fell 8.5%, and Bausch Health was down 8.3%.
Prestige Consumer Healthcare (PBH) shares jumped 13% after its fiscal Q3 adjusted earnings and revenue came in ahead of analysts' estimates.
Globus Medical (GMED) and Nevro (NVRO) said Thursday that Globus has agreed to buy Nevro in all-cash deal valued at $250 million. Globus shares fell 4% and Nevro surged 14%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.